Estimaciones de analistas de Wall Street para Aprea Therapeutics, Inc. (APRE): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-11 | $-0.08 | ||
| 2026-08-12 | $-0.07 | $-0.18 | +60.6% |
| 2026-05-13 | $-0.22 | $-0.23 | +4.3% |
| 2026-03-16 | $-0.32 | $-0.38 | +15.8% |
| 2025-11-12 | $-0.47 | $-0.11 | -327.3% |
| 2025-08-12 | $-0.53 | $-0.77 | +31.2% |
| 2025-05-14 | $-0.66 | $-0.65 | -0.9% |
| 2025-03-25 | $-0.49 | $-0.69 | +29.0% |
Ratios de valoración
| Precio / Valor contable | 0.41 |
| EV / EBITDA | 0.72 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | $583231 | $1.5M | 0 |
| Coste de Ventas | $7932 | $8316 | $170254 | $229610 | $271677 | $16.4M | $7052 | $9.4M | 0 |
| Beneficio Bruto | -$7932 | -$8316 | -$170254 | -$229610 | -$271677 | -$16.4M | $576179 | -$7.9M | 0 |
| I+D | $13.4M | $14.2M | $21.0M | $37.9M | $23.9M | $92.4M | $7.6M | $9.4M | $7.0M |
| Generales y Administrativos | $2.5M | $2.3M | $8.4M | $14.9M | $13.6M | $21.0M | $8.4M | $6.5M | $6.5M |
| Gastos Operativos | $15.9M | $16.5M | $29.4M | $52.8M | $37.2M | $97.0M | $16.0M | $6.5M | $13.2M |
| Beneficio Operativo | -$15.9M | -$16.5M | -$29.5M | -$52.8M | -$37.4M | -$113.4M | -$15.5M | -$14.3M | -$13.2M |
| EBITDA | -$15.2M | -$15.5M | -$27.9M | -$53.2M | -$36.9M | -$37.4M | -$14.3M | -$12.9M | -$12.6M |
| Gastos por Intereses | $15 | $182 | $156351 | $222652 | 0 | $448667 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$15.2M | -$15.5M | -$28.1M | -$53.5M | -$37.1M | -$112.7M | -$14.3M | -$13.0M | -$12.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$15.2M | -$15.5M | -$28.1M | -$53.9M | -$36.5M | -$112.7M | -$14.3M | -$13.0M | -$12.6M |
| BPA | $-21.58 | $-22.06 | $-26.28 | $-50.61 | $-34.88 | $-1359.79 | $-3.95 | $-2.35 | $-1.93 |
| BPA Diluido | $-21.58 | $-22.06 | $-26.28 | $-50.61 | $-34.88 | $-1359.79 | $-3.95 | $-2.35 | $-1.93 |
| Acciones en Circulación (Diluidas) | $703783 | $703783 | $1.0M | $1.1M | $1.1M | $82852 | $3.6M | $5.5M | $6.5M |
Precio
| Precio | $0.73 |
| Capitalización | $9M |
| Bolsa | NASDAQ |
| País | US |
Empresas relacionadas: ACXP · ADIL · APVO · BCDA · CELZ · GLTO · HCWB
Explorar sector: Healthcare · Biotechnology
Más secciones de APRE: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones